Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow-to-Debt Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow-to-Debt Ratio of 0.21x as of December 2025, meaning its operating cash flow of TL140.82 Million could theoretically repay 0% of its total liabilities (TL661.10 Million) in one year. See how much free cash does Meditera Tibbi Malzeme Sanayi ve Ticaret generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Also explore Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year debt coverage analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For market capitalisation and broader financial context, see MEDTR market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | TL435.35 Million | TL661.10 Million | ▼ -36.5% |
| 2024 | 1.04x | TL780.69 Million | TL752.75 Million | ▼ -22.8% |
| 2023 | 1.34x | TL801.02 Million | TL596.54 Million | ▲ +5492.3% |
| 2022 | 0.02x | TL5.10 Million | TL212.41 Million | ▼ -90.2% |
| 2021 | 0.24x | TL36.64 Million | TL149.84 Million | ▼ -58.4% |
| 2020 | 0.59x | TL73.26 Million | TL124.53 Million | ▲ +175.6% |
| 2019 | 0.21x | TL20.01 Million | TL93.72 Million | ▼ -72.2% |
| 2018 | 0.77x | TL73.26 Million | TL95.36 Million | — |